EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Advanced reperfusion therapies for acute pulmonary embolism in pregnancy and postpartum

Ioannis T Farmakis iD, Konstantinos C Christodoulou iD, Stefano Barco iD, Karsten Keller iD, Stavros V Konstantinides iD, Lukas Hobohm iD

European Heart Journal: Acute Cardiovascular Care · 2026

DOI: 10.1093/ehjacc/zuag047 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, 2026. Verfasst von Ioannis T Farmakis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Langenbeckstr. 1, Mainz 55131, Germany. Hauptthemen laut MEDLINE: Pregnancy Complications, Cardiovascular, Pulmonary Embolism, Reperfusion, Thrombolytic Therapy. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Pulmonary embolism (PE) remains the leading preventable cause of maternal death in high-income countries. Data on the management of acute PE during pregnancy are limited because pregnant women are systematically excluded from interventional trials. We evaluated the use and outcomes of advanced reperfusion therapies in pregnancy-associated PE.

Methods

We performed a cross-sectional analysis of the US Nationwide Inpatient Sample from 2016 through 2020. Pregnancy- and puerperium-related hospitalizations were identified using the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes. High-risk PE was defined by shock, mechanical ventilation, cardiac arrest, cardiopulmonary resuscitation, or vasopressor support. Advanced reperfusion therapies included systemic thrombolysis (ST), catheter-directed therapy (CDT), surgical embolectomy, and venoarterial extracorporeal membrane oxygenation (VA-ECMO).

Results

Among 19 741 880 pregnancy- or puerperium-related hospitalizations, 12 715 (0.06%) were complicated by PE, corresponding to 6.7 (95% CI, 6.6–6.8) hospitalizations per 10 000 live births. The overall in-hospital mortality rate was 0.86% (0.058 [95% CI, 0.048–0.070] deaths per 10 000 live births). Mortality was 0.2% among patients without haemodynamic instability and 29.1% among those with high-risk PE. Advanced reperfusion therapies were used in 3.4% of all pregnancy-associated PE cases and in 32.7% of high-risk cases. In-hospital mortality was 9.8% after ST, 10.7% after CDT, and 50% after VA-ECMO. Major bleeding occurred in 15.7%, 10.7%, and 50%, respectively.

Conclusion

Pregnancy-associated PE is rare but associated with high mortality in high-risk presentations. Advanced reperfusion therapies are used infrequently, reflecting the limited evidence, highlighting the need for multidisciplinary management, and further research and guidance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy Complications, CardiovascularPulmonary EmbolismReperfusionThrombolytic TherapyAdultFemaleHumansPregnancyAcute DiseaseCross-Sectional StudiesEmbolectomyHospital MortalityPostpartum PeriodUnited States

Stichwörter der Autor:innen

Catheter-directed therapyMaternal mortalityPregnancyPulmonary embolismSystemic thrombolysis

Autor:innen und Institutionen

  • Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Langenbeckstr. 1, Mainz 55131, Germany.
  • Department of Medicine I, LMU University Hospital, LMU Munich, Germany.
  • Department of Cardiac and Vascular Surgery, University Medical Centre Mainz, Johannes Gutenberg University, Mainz, Germany.
  • Department of Angiology, University Hospital Zurich, Zurich, Switzerland.
  • Department of Cardiology, University Medical Center Mainz (Johannes Gutenberg-University Mainz), Mainz 55131, Germany.
  • Department of Cardiology, Democritus University of Thrace, Alexandroupolis, Greece.

ORCID-Profile: Ioannis T Farmakis, Konstantinos C Christodoulou, Stefano Barco, Karsten Keller, Stavros V Konstantinides, Lukas Hobohm

Zitieren

APA

Farmakis, I. T., Christodoulou, K. C., Barco, S., Keller, K., Konstantinides, S. V., & Hobohm, L. (2026). Advanced reperfusion therapies for acute pulmonary embolism in pregnancy and postpartum. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuag047

Vancouver

Farmakis IT, Christodoulou KC, Barco S, Keller K, Konstantinides SV, Hobohm L. Advanced reperfusion therapies for acute pulmonary embolism in pregnancy and postpartum. European Heart Journal: Acute Cardiovascular Care. 2026. doi:10.1093/ehjacc/zuag047

BibTeX
@article{Farmakis2026,
  author = {Farmakis, Ioannis T and Christodoulou, Konstantinos C and Barco, Stefano and Keller, Karsten and Konstantinides, Stavros V and Hobohm, Lukas},
  title = {Advanced reperfusion therapies for acute pulmonary embolism in pregnancy and postpartum},
  journal = {European Heart Journal: Acute Cardiovascular Care},
  year = {2026},
  doi = {10.1093/ehjacc/zuag047}
}
Kostenlos starten →